Prodev Pharma (Opc) Private Limited - Due diligence report

A 360° intelligence report on Prodev Pharma (Opc) Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2018-12-21 Hyderabad, Telangana Active Unlisted
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Prodev Pharma (Opc) Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Prodev Pharma (Opc) Private Limited is assessed as Low Risk with a Trust Score of 86/100. Prodev Pharma (Opc) Private Limited is an active company incorporated in 2018, operating in the Chemicals sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 22 Nov 2026 from the latest processed filings. Prodev Pharma (Opc) Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
70/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 0 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 70/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open ( 48.0 cr ) · 0 satisfied ( 12.5 cr ).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 70/100
NameDIN / PANDesignationAppointedTenureDIN status
VENKATA NAGA BRAHMESWARA RAO MANDAVA 01234567 Director 01/04/2018 6 yrs Approved
  • Board below statutory minimum.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2026 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Net margin improved to 0.86.
Operating for 7 years.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment82/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view81/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 3 events
31 Mar 2025
Latest balance sheet
Filed with ROC
21 Dec 2018
Incorporated
Registered with Roc Hyderabad
Director appointed
VENKATA NAGA BRAHMESWARA RAO MANDAVA (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
1 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Biozeal Healthcare Private Limited U24230PN2019PTC187498 Pune, Maharashtra, India
Modi Paint Private Limited U24220DL2013PTC262850 New Delhi, Delhi, India
Gujarat Ports Infrastructure And Development Company Limited U24230GJ1982SGC005422 Gandhinagar, Gujarat, India
See Ever Healthcare Private Limited U24299HR2019PTC077696 Shahabad Markanda, Haryana, India
Keaterra Chemicals Private Limited U24290DL2018PTC338438 Delhi, Delhi, India
Alifvet Private Limited U24299MH2021PTC366451 Mumbai, Maharashtra, India
Kedarnath Pipe Private Limited U24106OD2023PTC044255 Cuttack Sadar, Orissa, India
Aka Ingredients Specialties Private Limited U24110UP2020PTC134740 Ghaziabad, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Prodev Pharma (Opc) Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Prodev Pharma (Opc) Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Prodev Pharma (Opc) Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Prodev Pharma (Opc) Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Prodev Pharma (Opc) Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Prodev Pharma (Opc) Private Limited an active company?

Prodev Pharma (Opc) Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Prodev Pharma (Opc) Private Limited financially healthy?

Prodev Pharma (Opc) Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Prodev Pharma (Opc) Private Limited?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Prodev Pharma (Opc) Private Limited?

See the directors and ownership sections above for board and shareholding detail. 1 active director(s) are on record.

Does Prodev Pharma (Opc) Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Prodev Pharma (Opc) Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Prodev Pharma (Opc) Private Limited?

Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.